Year 2015, Volume 28 , Issue 1, Pages 1 - 2 2015-09-30

Proceedings in oncology: Aren’t we back to the future?

Perran Fulden YUMUK [1]


Three weeks ago Pamir Atagunduz, the Chief Editor of
Marmara Medical Journal, talked to me about his plans for
the Journal in the upcoming years with great excitement
and enthusiasm. I felt honored when he asked if I would
be interested in becoming the invited editor for the first of
the “Special Issue” series of Marmara Medical Journal. The
same day I started to plan how to accomplish an oncology
issue in a very short period of time. When I called Esra
Saglam, asking for a review due in 3 weeks, not only she
said yes, but also encouraged me with her great ideas. Here,
I would especially thank to all of the authors in this issue for
writing these manuscripts despite their very busy schedule.
Also, I owe special thanks to Bruce Minsky for his positive
approach in contributing to our Journal.
In addition to the current information regarding positive
interaction between immunotherapy and radiotherapy you
will find the latest developments on treatment of various
cancers in this “Special Issue - Oncology “.

  • References
  • Minsky B. Advances in the management of esophageal
  • cancer. Marmara Med J 2015; 28 (Special Issue 1):3-10.
  • doi:10.5472/mmj.10059
  • Dane F. What to expect from HER-2 directed therapies
  • in advanced gastric cancer? Marmara Med J 2015; 28
  • (Special Issue 1):11-15. doi:10.5472/mmj.87204
  • Akgun Z, Saglam EK. Neoadjuvant treatment in locally
  • advanced rectal cancer. Marmara Med J 2015; 28
  • (Special Issue 1):16-20. doi:10.5472/mmj.43321
  • Igdem S. Treatment of prostate cancer by hypofractionated
  • radiotherapy. Marmara Med J 2015; 28 (Special Issue
  • :21-23. doi:10.5472/mmj.11680
  • Bavbek S. How to approach castration-resistant prostate
  • cancer? Marmara Med J 2015; 28 (Special Issue 1):24-
  • doi:10.5472/mmj.80248
  • http://www.accessdata.fda.gov/drugsatfda_docs/
  • appletter/2015/207103Orig1s000ltr.pdf
  • Aktas B. CDK inhibitors in hormone receptor positive
  • advanced breast cancer. Marmara Med J 2015; 28
  • (Special Issue 1):35-39. doi:10.5472/mmj.77406
  • Anacak Y, Kamer S, Sert F. Combining radiotherapy with
  • immunotherapy. Marmara Med J 2015; 28 (Special Issue
  • :40-44. doi:10.5472/mmj.34632
  • ht tp: / /www.fda.gov/NewsEvents/Newsroom/
  • PressAnnouncements/ucm436534.htm
  • https://clinicaltrials.gov/ct2/show/NCT01642004?term
  • =CheckMate+017&rank=1
  • http://www.medscape.com/viewarticle/840890
Primary Language en
Journal Section Editorial
Authors

Author: Perran Fulden YUMUK

Dates

Publication Date : September 30, 2015

Bibtex @ { marumj2883, journal = {Marmara Medical Journal}, issn = {1019-1941}, eissn = {1309-9469}, address = {}, publisher = {Marmara University}, year = {2015}, volume = {28}, pages = {1 - 2}, doi = {10.5472/mmj.37882}, title = {Proceedings in oncology: Aren’t we back to the future?}, key = {cite}, author = {Yumuk, Perran Fulden} }
APA Yumuk, P . (2015). Proceedings in oncology: Aren’t we back to the future? . Marmara Medical Journal , Special Issue :1 Oncology , 1-2 . DOI: 10.5472/mmj.37882
MLA Yumuk, P . "Proceedings in oncology: Aren’t we back to the future?" . Marmara Medical Journal 28 (2015 ): 1-2 <https://dergipark.org.tr/en/pub/marumj/issue/408/2883>
Chicago Yumuk, P . "Proceedings in oncology: Aren’t we back to the future?". Marmara Medical Journal 28 (2015 ): 1-2
RIS TY - JOUR T1 - Proceedings in oncology: Aren’t we back to the future? AU - Perran Fulden Yumuk Y1 - 2015 PY - 2015 N1 - doi: 10.5472/mmj.37882 DO - 10.5472/mmj.37882 T2 - Marmara Medical Journal JF - Journal JO - JOR SP - 1 EP - 2 VL - 28 IS - 1 SN - 1019-1941-1309-9469 M3 - doi: 10.5472/mmj.37882 UR - https://doi.org/10.5472/mmj.37882 Y2 - 2021 ER -
EndNote %0 Marmara Medical Journal Proceedings in oncology: Aren’t we back to the future? %A Perran Fulden Yumuk %T Proceedings in oncology: Aren’t we back to the future? %D 2015 %J Marmara Medical Journal %P 1019-1941-1309-9469 %V 28 %N 1 %R doi: 10.5472/mmj.37882 %U 10.5472/mmj.37882
ISNAD Yumuk, Perran Fulden . "Proceedings in oncology: Aren’t we back to the future?". Marmara Medical Journal 28 / 1 (September 2015): 1-2 . https://doi.org/10.5472/mmj.37882
AMA Yumuk P . Proceedings in oncology: Aren’t we back to the future?. Marmara Med J. 2015; 28(1): 1-2.
Vancouver Yumuk P . Proceedings in oncology: Aren’t we back to the future?. Marmara Medical Journal. 2015; 28(1): 1-2.
IEEE P. Yumuk , "Proceedings in oncology: Aren’t we back to the future?", Marmara Medical Journal, vol. 28, no. 1, pp. 1-2, Sep. 2015, doi:10.5472/mmj.37882